Live Science on MSN
Color blindness linked to lower bladder cancer survival, early study hints
People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...
D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...
A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.
MedPage Today on MSN
Color blindness and bladder cancer: A bad combination for survival?
Study suggests inability to identify blood in urine may delay diagnosis and reduce surviva ...
No significant difference seen between patients with colorectal cancer and color vision deficiency versus those without color vision deficiency.
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...
As soon as the urologist said, oh it’s cancer…that is an eye-opener,” says Mark Stiegler, reflecting on his diagnosis six ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...
In a significant development for the field of oncology, ImmunityBio, Inc. (NASDAQ: IBRX) has recently announced positive results from its clinical trials focused on treating bladder cancer. This ...
On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.
Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback